NEUROCRINE BIOSCIENCES INC
10-Q, EX-27, 2000-11-08
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NEUROCRINE BIOSCIENCES INC, 10-Q, 2000-11-08
Next: NICHOLAS APPLEGATE CAPITAL MANAGEMENT, 13F-HR, 2000-11-08



<TABLE> <S> <C>

<ARTICLE>                                           5
<MULTIPLIER>                                        1,000

<S>                                                 <C>
<PERIOD-TYPE>                                       9-MOS
<FISCAL-YEAR-END>                                   Dec-31-2000
<PERIOD-START>                                      Jan-01-2000
<PERIOD-END>                                        Sep-30-2000
<CASH>                                                            11,163
<SECURITIES>                                                      68,285
<RECEIVABLES>                                                      1,265
<ALLOWANCES>                                                           0
<INVENTORY>                                                            0
<CURRENT-ASSETS>                                                  82,618
<PP&E>                                                                 0
<DEPRECIATION>                                                         0
<TOTAL-ASSETS>                                                    96,260
<CURRENT-LIABILITIES>                                             10,377
<BONDS>                                                                0
                                                  0
                                                            0
<COMMON>                                                              22
<OTHER-SE>                                                        81,413
<TOTAL-LIABILITY-AND-EQUITY>                                      96,260
<SALES>                                                                0
<TOTAL-REVENUES>                                                  11,043
<CGS>                                                                  0
<TOTAL-COSTS>                                                     35,334
<OTHER-EXPENSES>                                                      47
<LOSS-PROVISION>                                                       0
<INTEREST-EXPENSE>                                                   173
<INCOME-PRETAX>                                                  (19,072)
<INCOME-TAX>                                                         302
<INCOME-CONTINUING>                                                    0
<DISCONTINUED>                                                         0
<EXTRAORDINARY>                                                        0
<CHANGES>                                                              0
<NET-INCOME>                                                     (19,374)
<EPS-BASIC>                                                        (0.88)
<EPS-DILUTED>                                                      (0.88)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission